{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-015602","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2026-04-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.797687+00:00","generated_at":"2026-05-15T06:53:58.886843+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"confidence":"high","headline":"Ensysce closes $2M preferred stock financing from prior $20M commitment; conversion price $0.55","bullets":["Gross proceeds of $2M from second tranche under November 2025 agreement; net ~$1.9M for TAAP and MPAR programs and working capital.","Conversion price fixed at $0.55 per share; warrants with 100% coverage (18-month and 5-year terms) at $0.55 exercise price.","Amended Series B preferred stated value from $1,100 to $1,200 per share and issued 8,727,273 warrants.","CEO Lynn Kirkpatrick states financing reflects continued investor confidence in the company's analgesic programs.","Financing is part of up to $20M commitment available over 24 months from institutional investor."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-015602","json":"https://secwatch.observer/filing/0001493152-26-015602.json","markdown":"https://secwatch.observer/filing/0001493152-26-015602.md","text":"https://secwatch.observer/filing/0001493152-26-015602.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226015602/0001493152-26-015602-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226015602/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:53:58.886843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}